A validation study of the European Society of Cardiology guidelines for risk stratification of sudden cardiac death in childhood hypertrophic cardiomyopathy
暂无分享,去创建一个
R. Omar | J. Kaski | T. Bharucha | Caroline B. Jones | A. Lota | S. Mathur | P. Daubeney | G. Stuart | K. McLeod | O. Uzun | T. Ding | M. Ilina | G. Norrish | E. Field | V. Bhole | Elspeth Brown | K. Linter | S. Adwani | Z. Reinhardt | K. Kok | C. Jones | Caroline B. Jones | Khoon Li Kok
[1] J. Kaski,et al. Clinical presentation and survival of childhood hypertrophic cardiomyopathy: a retrospective study in United Kingdom , 2018, European heart journal.
[2] S. Colan,et al. Long-Term Outcomes of Hypertrophic Cardiomyopathy Diagnosed During Childhood: Results From a National Population-Based Study , 2018, Circulation.
[3] A. Keren,et al. International External Validation Study of the 2014 European Society of Cardiology Guidelines on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (EVIDENCE-HCM) , 2017, Circulation.
[4] P. Elliott,et al. Risk factors for sudden cardiac death in childhood hypertrophic cardiomyopathy: A systematic review and meta-analysis , 2017, European journal of preventive cardiology.
[5] B. Maron,et al. Independent Assessment of the European Society of Cardiology Sudden Death Risk Model for Hypertrophic Cardiomyopathy. , 2015, The American journal of cardiology.
[6] F. Rutten,et al. [2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy]. , 2014, Kardiologia polska.
[7] Giuseppe Limongelli,et al. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). , 2014, European heart journal.
[8] C. Henrikson,et al. Implanted Defibrillators in Young Hypertrophic Cardiomyopathy Patients: A Multicenter Study , 2013, Pediatric Cardiology.
[9] P. Lambiase,et al. A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy , 2013, Heart.
[10] Barry J Maron,et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2011, The Journal of thoracic and cardiovascular surgery.
[11] J. Towbin,et al. Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children. , 2009, Journal of the American College of Cardiology.
[12] P. Elliott,et al. Prevalence of Sarcomere Protein Gene Mutations in Preadolescent Children With Hypertrophic Cardiomyopathy , 2008, Circulation. Cardiovascular genetics.
[13] Wei Du,et al. Regression equations for calculation of z scores of cardiac structures in a large cohort of healthy infants, children, and adolescents: an echocardiographic study. , 2008, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[14] S. Colan,et al. Epidemiology and Cause-Specific Outcome of Hypertrophic Cardiomyopathy in Children: Findings From the Pediatric Cardiomyopathy Registry , 2007, Circulation.
[15] P. Elliott,et al. Outcomes after implantable cardioverter-defibrillator treatment in children with hypertrophic cardiomyopathy , 2006, Heart.
[16] J. Carlin,et al. Clinical Features and Outcomes of Childhood Dilated Cardiomyopathy: Results From a National Population-Based Study , 2005, Circulation.
[17] J. Carlin,et al. Clinical Features and Outcomes of Childhood Hypertrophic Cardiomyopathy: Results From a National Population-Based Study , 2005, Circulation.
[18] Yvonne Vergouwe,et al. Substantial effective sample sizes were required for external validation studies of predictive logistic regression models. , 2005, Journal of clinical epidemiology.
[19] John B Carlin,et al. The epidemiology of childhood cardiomyopathy in Australia. , 2003, The New England journal of medicine.
[20] E John Orav,et al. The incidence of pediatric cardiomyopathy in two regions of the United States. , 2003, The New England journal of medicine.
[21] O. Simell,et al. Epidemiology of idiopathic cardiomyopathies in children and adolescents. A nationwide study in Finland. , 1997, American journal of epidemiology.
[22] J. Deanfield,et al. Hypertrophic cardiomyopathy: an important cause of sudden death. , 1984, Archives of disease in childhood.
[23] G. Schwartz,et al. Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults. , 1978, The Journal of pediatrics.